Immunity Inflammation and Disease,
Journal Year:
2023,
Volume and Issue:
11(10)
Published: Oct. 1, 2023
The
aim
of
the
study
is
to
investigate
role
serum
inflammatory
factors
and
T-cell
subsets
in
diagnosis
recurrence
epithelial
ovarian
cancer
patients
effect
olaparib
on
factor
T-lymphocyte
with
recurrent
cancer.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(1), P. 125 - 125
Published: Jan. 8, 2024
Insulin-like
growth
factor-binding
protein
(IGFBP)-2
is
a
regulator
of
anabolic
pathways,
which
become
inactivated
in
severe
illness.
Here,
we
measured
the
serum
IGFBP-2
levels
COVID-19
patients
with
moderate
and
disease
as
well
healthy
controls
to
identify
associations
severity.
Patients
had
higher
than
those
controls,
who
similar
levels.
Non-survivors
tended
have
elevated
compared
survivors.
Increased
were
observed
requiring
dialysis
vasopressor
therapy.
Serum
was
positively
correlated
procalcitonin
both
patient
groups.
Bacterial
co-infection
did
not
influence
liver
cirrhosis
obesity,
showing
increased
decreased
levels,
respectively,
excluded
from
study.
The
present
analysis
showed
that
are
associated
severity
patients.
similarity
between
suggests
critical
illness
rather
SARS-CoV-2
infection
itself.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(21), P. 11411 - 11411
Published: Oct. 24, 2024
IL-6
remains
a
key
molecule
of
the
cytokine
storms
characterizing
COVID-19,
exerting
both
proinflammatory
and
anti-inflammatory
effects.
Emerging
research
underscores
significance
trans-signaling
over
classical
signaling
pathways,
which
has
shifted
focus
therapeutic
strategies.
Additionally,
synergistic
action
TNF-α
IFN-γ
been
found
to
induce
inflammatory
cell
death
through
PANoptosis,
further
amplifying
severity
storms.
Long
COVID-19
patients,
as
well
those
with
triggered
by
other
conditions,
exhibit
distinct
laboratory
profiles,
indicating
need
for
targeted
approaches
diagnosis
management.
Growing
evidence
also
highlights
gut
microbiota's
crucial
role
in
modulating
immune
response
during
affecting
production,
adding
complexity
disease's
immunological
landscape.
Targeted
intervention
strategies
should
on
specific
cutoffs,
though
accurate
quantification
clinical
challenge.
Current
treatment
are
increasingly
focused
inhibiting
trans-signaling,
offers
promise
more
precise
manage
hyperinflammatory
responses
COVID-19.
In
light
recent
discoveries,
this
review
summarizes
findings
storms,
particularly
their
conditions.
It
explores
emerging
targeting
cytokines
like
IL-6,
TNF-α,
IFN-γ,
while
addressing
open
questions,
such
better
biomarkers
detect
ongoing
challenges
developing
treatments
that
mitigate
hyperinflammation
without
compromising
function,
emphasizing
importance
continued
field.
Deleted Journal,
Journal Year:
2025,
Volume and Issue:
2(1)
Published: Jan. 13, 2025
The
exploration
of
latex
from
medicinal
plants
has
unveiled
a
promising
source
antimicrobial
peptides
(AMPs),
proteins
and
enzymes
with
significant
therapeutic
potentials.
Despite
their
value,
these
sources
remain
underutilized.
Latex,
complex,
viscous
fluid
secreted
by
specific
plants,
in
the
Euphorbiaceae,
Apocynaceae,
Moraceae,
Papaveraceae,
Asclepiadaceae
families,
serves
multiple
functions,
including
wound
healing,
protection
against
herbivores,
most
importantly,
as
defense
microbial
pathogens
This
review
provides
an
overview
latex-producing
emphasizing
role
discovery
molecules.
Notable
among
is
Hevea
brasiliensis,
hevein
hevein-like
peptides,
which
have
demonstrated
antifungal
antibacterial
activities.
Other
key
AMPs
are
cysteine-rich
lectins
that
exhibit
potent
properties.
Additionally,
peptidases
proteases
obtained
garnered
attention
for
potential
both
activity
enhancement
peptide
stability
efficacy.
These
molecules
act
through
unique
mechanisms,
disrupting
cell
membranes,
making
them
valuable
candidates
fight
multidrug-resistant
pathogens.
They
underscore
contribution
to
modern
research.
While
discoveries
hold
great
promises,
some
challenges
still
exist.
Interestingly,
biotechnology
advancements
synthesis
genetic
engineering
improved
latex-derived
biomolecules
enabling
large-scale
production
modification,
enhancing
stability,
potency,
effectiveness
use.
Also,
integration
genomic
proteomic
tools
will
further
unlock
full
potentials,
paving
way
novel
agents
capable
addressing
antibiotic
resistance.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 17, 2025
Abstract
Cytokines
and
chemokines
are
essential
for
establishing
an
appropriate
immune
response
to
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2).
Variations
in
the
genes
encoding
cytokines
strongly
influence
pathogenic
challenges
disease
outcomes.
This
study
was
carried
out
determine
associations
of
polymorphisms
TNF
-α
,
IL-6
IL-8,
IL-10
CCL5
with
COVID-19
severity.
A
total
627
unvaccinated
patients
were
classified
according
WHO
We
evaluated
levels
IFN-α,
IFN-γ,
TNF-α,
IL-1R,
IL-6,
IL-7,
IL-10,
CCL2,
CCL3,
CXCL8,
CXCL10
GCSF
serum
compared
among
severity
groups
stratified
by
polymorphism
alleles.
revealed
a
significant
increase
IL-2,
CCL-2
dead
group.
However,
higher
moderate
group
than
mild
Logistic
regression
analysis
that
five
associated
increased
risk
COVID-19:
(rs1800610)
allele
(OR=1.50;
95%
CI:
1.01–2.24);
(rs1800796)
C
(OR=1.64;
1.05–2.57);
(rs1800871)
T
(OR=1.94;
1.24–3.04)
(rs1800872)
(OR=1.87;
1.21–2.89);
(rs3817656)
G
(OR=
1.64;
1.02–2.65)).
The
(rs1800871
rs1800872)
(rs1800796
rs18049563)
gene
also
Increases
carriers
rs1049953.
In
contrast,
not
any
SNPs.
Respiratory Research,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: March 22, 2025
Abstract
The
coronavirus
disease
2019
(COVID-19)
global
pandemic
is
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
However,
our
understanding
of
SARS-CoV-2-induced
inflammation
in
alveolar
epithelial
cells
remains
very
limited.
contributions
intracellular
insulin-like
growth
factor
binding
protein-2
(IGFBP2)
to
SARS-CoV-2
pathogenesis
are
also
unclear.
In
this
study,
we
have
uncovered
a
critical
role
for
IGFBP2,
specifically
type
(AEC2),
the
immunopathogenesis
COVID-19.
Using
bulk
RNA
sequencing,
show
that
IGFBP2
mRNA
expression
significantly
downregulated
primary
AEC2
isolated
from
fibrotic
lung
regions
patients
with
COVID-19-acute
distress
(ARDS)
compared
those
idiopathic
pulmonary
fibrosis
(IPF)
alone
or
IPF
history
multicolor
immunohistochemistry,
demonstrated
and
its
selective
ligands
IGF1
IGF2
were
reduced
COVID-ARDS,
alone,
COVID
than
age-matched
donor
controls.
Further,
lentiviral
Igfbp2
proinflammatory
cytokines—Tnf-α,
Il1β,
Il6,
Stat3,
Stat6
chemokine
receptors—Ccr2
Ccr5—in
mouse
challenged
spike
protein
injury
(S2;
500
ng/mL).
Finally,
higher
levels
cytokines—TNF-α;
IL-6
receptor—CCR5
COVID-ARDS
patients.
Altogether,
these
data
suggest
anti-inflammatory
properties
localized
delivery
may
serve
as
potential
therapeutic
strategy
Graphical
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 28, 2025
The
global
COVID-19
pandemic
has
led
to
significant
advancements
in
vaccine
research,
particularly
regarding
patients
with
autoimmune
inflammatory
rheumatic
diseases
(AIIRD).
However,
most
studies
have
assessed
the
post-vaccination
cellular
response
only
by
measuring
production
of
interferon-gamma.
This
study
aimed
explore
immune
AIIRD,
a
focus
on
effects
immunomodulatory
drugs
different
proteins
involved
and
cytotoxicity.
We
analyzed
blood
samples
from
54
-
16
healthy
controls
(HC)
38
AIIRD
at
three
time
points:
before
(T0),
4
weeks
after
(T1),
more
than
6
months
(T2)
booster
vaccination.
Gene
expression
concentration
levels
13
immunity
were
assessed.
Our
showed
significantly
reduced
TNF
T0,
IL-2
T0
T2,
perforin
T2
compared
HC.
In
genes
cytotoxicity,
including
NRF2,
TRAIL,
cathepsin
B,
H
was
impaired.
Both
protein
concentrations
gene
altered
those
treated
glucocorticoids,
methotrexate,
biologic/targeted
synthetic
disease-modifying
antirheumatic
(b/tsDMARDs).
Among
b/tsDMARDs
IL-17
inhibitors
did
not
affect
response.
These
findings
suggest
that
vaccination
elicits
weakened
immunosuppressive
therapies,
potentially
compromising
efficacy.
Further
are
required
determine
clinical
impact
these
long-term
effectiveness
this
population.